# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

Submitter Address Phone number Fax number

ELITech Vital Scientific BV   
Van Rensselaerweg 4, 6956 AV SPANKEREN, The Netherlands   
+ 31 (0) 313 430 501   
$^ +$ 33 (0) 313 427 807

# Contact

Colinda van den Broek (Email: c.vandenbroek@elitechgroup.com)

Date of Preparation

Thursday, September 9th 2010

# Device name

Trade/proprietary Name: Common or Usual Name: Regulatory:

ELITech Clinical Systems Selectra ProM Clinical analyzer, "ProM"   

<table><tr><td rowspan=1 colspan=1>Code</td><td rowspan=1 colspan=1>Name  .</td><td rowspan=1 colspan=1>Class</td><td rowspan=1 colspan=1>$frac}$Regulation</td><td rowspan=1 colspan=1>Regulation Name</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>JJE</td><td rowspan=1 colspan=1>analyzer, chemistry(photometric, discrete),for clinical use</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>21 CFR 862.2160</td><td rowspan=1 colspan=1>Discrete photometric chem-istry analyzer for clinical use</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>JGS</td><td rowspan=1 colspan=1>Electrode, Ion-Specific, Sodium</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>21 CFR 862.1665</td><td rowspan=1 colspan=1>Sodium test system</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>CEM</td><td rowspan=1 colspan=1>Electrode, Ion-Specific, Potassium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1600</td><td rowspan=1 colspan=1>Potassium test system</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>CGZ</td><td rowspan=1 colspan=1>Electrode, Ion-Specific, Chloride</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1170</td><td rowspan=1 colspan=1>Chloride test system</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>CIT</td><td rowspan=1 colspan=1>NADH oxidation/NADreduction, AST/SGOT</td><td rowspan=1 colspan=1>I1</td><td rowspan=1 colspan=1>21 CFR 862.1100</td><td rowspan=1 colspan=1>Aspartate amino transferase(AST/SGOT) Test system</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>JIX</td><td rowspan=1 colspan=1>calibrator, multi-analyte mixture</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>21 CFR 862.1150</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr><tr><td rowspan=1 colspan=1>JJY</td><td rowspan=1 colspan=1>multi-analyte con-trols, all kinds (as-sayed)</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>21 CFR 862.1660</td><td rowspan=1 colspan=1>Quality control material (as-sayed and unassayed)</td><td rowspan=1 colspan=1>75 ClinicalChemistry</td></tr></table>

# Establishment Information:

The establishment registration number for ELITech Vital Scientific BV is 8030478.   
The establishment registration number for ELITech SEPPIM SAS is 3007662974.   
The establishment registration number for ELITech Wescor USA is 1717966.   
The owner operator number for ELITech North America (Wescor, Logan, UT, USA) is 1717966.

# Predicate device:

<table><tr><td rowspan=1 colspan=1>Predicate Instrument or reagent</td><td rowspan=1 colspan=1>510(k) Number</td><td rowspan=1 colspan=1>Product code(s)              </td></tr><tr><td rowspan=1 colspan=1>HORIBA ABX PENTRA 400</td><td rowspan=1 colspan=1>K052007</td><td rowspan=1 colspan=1>JJE JIX (also CEM CGZ JGS)</td></tr><tr><td rowspan=1 colspan=1>ROCHE cobas c111</td><td rowspan=1 colspan=1>K071211</td><td rowspan=1 colspan=1>JGS CEM CGZ CIT CFR JJE DCN</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA AST CP</td><td rowspan=1 colspan=1>K060318</td><td rowspan=1 colspan=1>CIT JIX JJY</td></tr><tr><td rowspan=1 colspan=1>Roche Diagnostics PrecinornUniversal and Precipath UniversalControl Sera</td><td rowspan=1 colspan=1>K041227</td><td rowspan=1 colspan=1>JJY</td></tr><tr><td rowspan=1 colspan=1>Roche Diagnostics Calibrator forAutomatic Systems (C.f.a.s.)</td><td rowspan=1 colspan=1>K033501</td><td rowspan=1 colspan=1>JIX</td></tr><tr><td rowspan=1 colspan=1>Roche Standards for the CobasISE Module</td><td rowspan=1 colspan=1>K897071</td><td rowspan=1 colspan=1>JIX</td></tr></table>

# Substantial Equivalence:

The ELITech Clinical Systems Selectra ProM is a new device developed by ELITech Vital Scientific BV. It has been demonstrated that the Selectra ProM is substantially equivalent to the predicate device, Horiba ABX PENTRA 400. The ISE Module is similarly demonstrated to be substantially equivalent to the ROCHE cobas c111 ISE. The ELITech Clinical Systems AST/GOT $4 + 1$ SL, calibrated with ELITech Clinical Systems ELICAL 2 and controlled with ELITech Clinical Systems ELITROL I and ELITROL I, is substantially equivalent to HORIBA ABX AST CP, calibrated with Multical and controlled with N Control and P Control.

# Device description

The Selectra ProM is an automated, in-vitro diagnostic analyzer capable of performing clinical chemistry, specific protein and electrolyte tests. Analytes are measured photometrically or turbidimetrically; the analyzer also has an ISE module for measuring sodium, potassium and chloride electrometrically.

The Selectra ProM instrument is a random access analyzer designed to beoperated on a bench top in he professional environment using a combination of a photometric analysis unit and an ion selective electrodes (ISE).

AST/GOT $4 + 1 \leq L$ is available as kit only. It consists of 2 reagents: Reagent 1 contains Tris buffer, LAspartate; Lactate dehydrogenase (LDH) (microorganisms), Malate dehydrogenase (MDH) (bacterial) and sodium azide. Reagent 2 contains $\pmb { \alpha }$ Ketoglutarate, NADH and sodium azide.

The Sodium, Potassium and Chloride ISE Electrodes are comprised of the electrodes plus ISE Reference Solution, ISE Diluent, ISE Calibrators.

ELITech Clinical Systems ELICAL 2 is a lyophilized calibrator based on human serum containing constituoensue optimal caliratinLAL s prepare exclusively from he blood  donors testvidually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDAapproved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

ELITROL I and ELITROL I are two level quality control products consisting of lyophilized human serum containing constituents at desired levels. ELITROL I and ELITROL 1l are prepared exclusively frpm the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Performance Standards

To date, no performance standards that affect this device have been finalized under Section 514 of the Act.

# Intended Use

See Indications for Use following

# Indications for Use:

Selectra ProM analyzer:

The ELITech Clinical system Selectra ProM is an automated clinical chemistry system intended for use in cncal laboratores. It is intended to be used for a variety f assay methods that have been appled to spectrophotometric and electrochemical techniques. The system has two core modules: one consisting of a spectrophotometric system for measurement of analytes using spectrophotometric techniques, such as ed point, rate and turbidimetric assays. The second module is an electrometer used for measurement of electrolytes.

For in vitro diagnostic use only.

# Reagents:

ELITech Clinical Systems AST/GOT $4 + 1$ SLs a reagent orthe quantitative in vidiagnosticdetermia tion of the activity of the enzyme Aspartate Amino Transferase (AST) in human serum and plasma on ELITech Clinical Systems Selectra ProM analyzer. Aspartate Amino Transferase measurements are used in the diagnosis and treatment of certain types of liver and heart disease.

ELTeh Clinical Systems LCALsmulti-parametricalibrator or i vio diagnosticsen hcalibration of quantitative ELITech Clinical Systems methods on the ELITech Clinical Systems Selectra ProM analyzers.

ELITech Clinical Systems ELITROL I & ELITROL I are multiparametric control sera for in vitro diagnostic use in accuracy and precision of quantitative ELITech Clinical Systems methods on ELTech Clinical Systems Selectra ProM analyzer equipped with ISE module.

ELITech Clinical Systems ISE Calibrators are used for the caliration of sodium $( N a + )$ potassium $( \mathsf { K } { + } ) ,$ and chloride (CI-) on ELITech Clinical Systems Selectra ProM analyzer equipped with ISE module.

# ISE: ISE Sodium Electrode

The sodium electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of sodium in serum and plasma. Sodium measurements are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excreton of large amounts o diluteurine accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion or other diseases involving electrolyte imbalance.

ISE Potassium Electrode

The potassium electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of potassium in serum and plasma. Potassium measurements are used to monitor elctrolyte balance in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

# ISE Chloride Electrode

The Chloride electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of chloride in serum and plasma.Chloride measurements are used in the diagnosis an treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

# Comparison to Predicate device ANALYZER

<table><tr><td rowspan=1 colspan=3>Similarities and Differences</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems Device(Selectra PröM)(AST/GOT.4+1SL).</td><td rowspan=1 colspan=1>Predicate device(ABX PENTRA 400 K052007)(ABX PENTRA AST CP K060318)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The ELITech Clinical system SelectraProM is an automated clinical chemis-try system intended for use in clinicallaboratories. It is intended to be usedfor a variety of assay methods thathave been applied to spectropho-tometric and electrochemical tech-niques. The system has two coremodules: one consisting of a spectro-photometric system for measurementof analytes using spectrophotometrictechniques, such as end point, rateand turbidimetric assays. The secondmodule is an electrometer used formeasurement of electrolytes.For in vitro diagnostic use only.</td><td rowspan=1 colspan=1>An automated clinical chemistry sys-tem intended for use in centralizedlaboratories. It is intended to be usedfor a variety of assay methods thathave been applied to spectropho-tometric and electrochemical tech-niques.</td></tr><tr><td rowspan=1 colspan=1>Operators</td><td rowspan=1 colspan=1>Professional setting</td><td rowspan=1 colspan=1>Professional setting</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Similarities and Differences</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems Device(Selectra ProM)(AST/GOT 4+1 SL)</td><td rowspan=1 colspan=1>Predicate device(ABX PENTRA 400 K052007):(ABX PENTRA AST CP K060318)</td></tr><tr><td rowspan=1 colspan=1>Intended use/Indications forUse</td><td rowspan=1 colspan=1>The Selectra ProM is an automatedclinical chemistry system intended foruse in clinical laboratories. It is in-tended to be used for a variety ofassay methods that have been ap-plied to spectrophotometric and elec-trochemical techniques.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Indication for Use forreagent</td><td rowspan=1 colspan=1>Measurements of aspartate aminotransferase used in the diagnosis andtreatment of certain types of liver andheart disease.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Assay protocol</td><td rowspan=1 colspan=1>Modified IFCC method without pyridoxal -phosphate</td><td rowspan=1 colspan=1>Optimized UV test according to IFCCmodified method without pyridoxalphosphate.</td></tr><tr><td rowspan=1 colspan=1>Composition</td><td rowspan=1 colspan=1>Reagent R1 :TRIS pH 7.8, 100 mmol/L; L- Aspartate330 mmol/L; MDH ≥ 1000 U/L; LDH ≥2000 U/L; Sodium azide &lt; 1g/LReagent R2 :α-Ketoglutarate 78 mmol/L ; NADH 1.1mmol/L ; Sodium azide &lt; 1g/L</td><td rowspan=1 colspan=1>Reagent R1 :TRIS pH 7.8 110 mmol/L; L- Aspartate340 mmo1/L; MDH ≥ 900 U/L; LDH ≥ 900U/L; Sodium azide &lt; 1g/LReagent R2 :2-oxoglutarate 85 mmol/L&quot;; NADH 1.09mmol/L ; Sodium azide &lt; 1g/L</td></tr><tr><td rowspan=1 colspan=1>Appearance of reagents</td><td rowspan=1 colspan=1>Liquid form, ready to use</td><td rowspan=1 colspan=1>Liquid form, ready to use</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Traceability/Standardization</td><td rowspan=1 colspan=1>IFCC formulation (Schumann, 2002),manual measurement</td><td rowspan=1 colspan=1>IFCC Reference Measurement Pro-cedure (37°C) for ASAT</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>SerumPlasma in lithium heparin</td><td rowspan=1 colspan=1>SerumPlasma in lithium heparin</td></tr><tr><td rowspan=1 colspan=1>Reagent storage</td><td rowspan=1 colspan=1>Store at 2-8 °C and protected fromlight. The reagents are stable until theexpiry date stated on the label</td><td rowspan=1 colspan=1>Reagents, in unopened cassette, arestable up to expiry date on the label ifstored at 2-8°C, and contamination isavoided.</td></tr><tr><td rowspan=1 colspan=1>Expected values</td><td rowspan=1 colspan=1>Serum, Plasma (37°C) :&lt; 40 U/L</td><td rowspan=1 colspan=1>Women &lt; 31 U/LMen &lt; 35 U/L     37°</td></tr><tr><td rowspan=1 colspan=1>Measuring range</td><td rowspan=1 colspan=1>10 to 250 U/L</td><td rowspan=1 colspan=1>3.70 U/L to 600 U/LAutomatic post-dilution:1800 U/L</td></tr><tr><td rowspan=1 colspan=1>Limit of detection (LoD)</td><td rowspan=1 colspan=1>0.8 U/L</td><td rowspan=2 colspan=1>4 U/L</td></tr><tr><td rowspan=1 colspan=1>Limit of quantification (LoQ)</td><td rowspan=1 colspan=1>5.0 U/L</td></tr><tr><td rowspan=1 colspan=1>Precision</td><td rowspan=1 colspan=1>Within runLevel 21.0 U/L CV=1.6%Level 54.1 U/L CV=0.6%Level 201.0 U/L CV=0.2%TotalLevel 21.0 U/L CV=2.1%Level 54.1 U/L CV=1.5%Level 201.0 U/L CV=1.4%</td><td rowspan=1 colspan=1>Within runLevel 42 U/L ·CV=2.7%Level 123 U/LCV=1.4%Level 22 U/L  CV=2.3%Level 38 U/L  CV=2.0%Level 145 U/LCV=1.1%TotalLevel 42 U/L  CV=3.1%Level 126 U/LCV=2.5%Level 43 U/L CV=3.6%Level 348 U/L CV=5.0%</td></tr><tr><td rowspan=1 colspan=1>Method comparison</td><td rowspan=1 colspan=1>y=1.028x - 0.16 U/L0.996range: 9.9 to 248.1 U/L</td><td rowspan=1 colspan=1>y=0.99x +1.01 U/L2=0.9966range: 3.70 to 671.80 U/L</td></tr><tr><td rowspan=1 colspan=1>Limitations</td><td rowspan=1 colspan=1>Turbidity: No significant interferenceup to 614 mg/dL (7 mmol/L).Pyruvate: No significant interferenceup to 3 mg/dL.Ascorbic acid: No significant inter-ference up to 20 mg/dL (1.1 mmol/L).Unconjugated bilirubin: No signifi-cant interference up to 30 mg/dL (513μmol/L).Conjugated bilirubin: No significantinterference up to 29.5 mg/dL (504μmol/L).NOTE: Hemolyzed samples should not beused since significant hemolysis mayincrease AST concentration because ofhigh levels of AST in Erythrocytes.</td><td rowspan=1 colspan=1>Hemoglobin: No significant influenceis observed up to 95 mg/dL.Triglycerides: No significant influ-ence is observed up to 402.5 mg/dL(as Intralipid® representative of li-pemia).Total bilirubin: No significant influ-ence is observed up to 415 umol/L.Direct bilirubin: No significant influ-ence is observed up to 362 µmol/L.</td></tr><tr><td rowspan=1 colspan=1>Calibration Frequency</td><td rowspan=1 colspan=1>28 days</td><td rowspan=1 colspan=1>8 days</td></tr><tr><td rowspan=1 colspan=1>On board stability</td><td rowspan=1 colspan=1>refrigerated area : 28 days</td><td rowspan=1 colspan=1>refrigerated area: 55 days</td></tr></table>

# CALIBRATOR:

Trade/proprietary Name: ELITech Clinical Systems ELICAL 2

Common or Usuai Name:   
Device Class   
Classification name   
Product code

Calibrator, multi-analyte mixture, "ELICAL 2" Class II Calibrator (21 CFR 862.1150) JIX- Calibrator, multi-analyte mixture

# Predicate device

Roche Diagnostics Calibrator for Automated Systems (C.f.a.s) (K033501)

# Device description

ELITech Clinical Systems ELICAL 2 is a lyophilized calibrator based on human serum containing constituents to ensure optimal calibration.

ELICAL 2 is prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Intended Use

ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems methods on the ELITech Clinical Systems Selectra ProM analyzers.

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech-Clinical Systems Device  2.        (ELICAL 2)</td><td colspan="1" rowspan="1">:.     Predicate device(Roche Calibrator f.a.s. K033501)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELICAL 2is a multi-parametric calibrator for invitro diagnostic use in the calibra-tion of quantitative ELITech ClinicalSystems methods on the ELITechClinical Systems Selectra ProManalyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in thecalibration of quantitative Rochemethods on Roche clinical chemis-try analysers as specified in thevalue sheets.</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td></tr><tr><td colspan="1" rowspan="1">Level</td><td colspan="1" rowspan="1">Single level</td><td colspan="1" rowspan="1">Single level</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilate, and pipette inexactly 3 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely by</td><td colspan="1" rowspan="1">Carefully open one bottle, avoidingthe loss of lyophilate, and pipette inexactly 3 ml of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely by</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">occasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">occasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">Traceability information is given inthe value sheet included in the box.</td><td colspan="1" rowspan="1">Traceability of the target value isgiven in the respective instructionfor use of the system reagents.</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :- 8 hours between 15-25 °C.- 2 days between 2-8 °C.- 4 weeks between -25 and -15 °C(when frozen once)</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expirationdate.After reconstitution, the stabilities*are :- 8 hours at 15-25 °C.- 2 days at 2-8 °C.- 4 weeks at (-25)-(-15) °C (whenfrozen once)*Exception for bilirubin total &amp; directas noted in package insert</td></tr></table>

# CONTROLS:

# ELITech Clinical Systems ELITROL I and ELITROL II

Trade/proprietary Name:   
Common or Usual Name:   
Device Class   
Classification name   
Product code   
Multi-analyte controls — all kinds, "ELITROL I". "ELITROL II   
Class I   
Quality control material (assayed and unassayed). (21 CFR 862.1660)   
JJX- Multi-analyte controls - all kinds

# Predicate device

Roche Diagnostics Precinorm U (K041227) Roche Diagnostics Precipath U (K041227)

# Device description

ELITech Clinical Systems ELITROL I and ELITROL II are two level quality control products consisting of lyophilized human serum containing constituents at desired levels.

Elitrol I and Elitrol il are prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Intended Use

ELITech Clinical Systems ELITROL I is a multi-parametric control serum for in vitro diagnostic use in accuracy control of quantitative ELITech Clinical Systems methods on the ELITech Clinical Systems ProM.

ELITech Clinical Systems ELITROL Il is a multi-parametric control serum for in vitro diagnostic use in accuracy control of quantitative ELITech Clinical Systems methods on the Vital Scientific Selectra ProM.

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems·DeviceELITROLT/ELITROL II</td><td colspan="1" rowspan="1">Predicate DeviceRoche Precinorm U / Precipath UK041227</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELITROL I &amp;ELITROL II are multiparametric controlsera for in vitro diagnostic use in accu-racy and precision of quantitativeELITech Clinical Systems methods onELITech Clinical Systems Selectra ProManalyzer equipped with ISE module.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in qualitycontrol by monitoring accuracy andprecision for the quantitative methodsas specified in the value sheet</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized human sera with constituentsadded as required to obtain desiredcomponents levels</td><td colspan="1" rowspan="1">Lyophilized human sera with constitu-ents added as required to obtain de-sired components levels</td></tr><tr><td colspan="1" rowspan="1">Levels</td><td colspan="1" rowspan="1">Two levels</td><td colspan="1" rowspan="1">Two levels</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding the lossof lyophilate, and pipette in exactly 5 mLof distilled/deionized water. Carefullyclose the vial and dissolve the contentscompletely by occasional gentle swirlingwithin 30 minutes avoiding the formationof foam.</td><td colspan="1" rowspan="1">Carefully open the bottle, avoiding theloss of lyophilate, and pipette in exactly5 mL of distilled/deionized water. Care-fully close the bottle and dissolve thecontents completely by occasionalgentle swirling within 30 minutes.Avoid the formation of foam.</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protected fromlight until the expiry dateAfter reconstitution, the stabilities are :- 12 hours between 15-25 °C.- 5 days between 2-8 °C.- 4 weeks between -25 and -15 °C (whenfrozen once)</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expiration date.After reconstitution, the stabilities* are :- 12 hours at 15-25 C.- 5 days at 2-8 C.- 4 weeks at (-25)-(-15) °C (when fro-zen once)*Exception for bilirubin total &amp; direct asnoted in package insert</td></tr><tr><td colspan="3" rowspan="1">Similarities and Differences</td></tr><tr><td colspan="1" rowspan="1">ISE MODULE2.</td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(Selectra ProM ISE Module)</td><td colspan="1" rowspan="1">Predicate device(ROCHE cobas C111 K071211)</td></tr><tr><td colspan="1" rowspan="1">Intended use/Indications forUse</td><td colspan="1" rowspan="1">The Selectra ProM ISE module is anelectrometer used for measurementof electrolytes.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">used for the quantitative in vitro diag-nostic determination of sodium (Nat),potassium (K*), and chloride (Cl) inhuman serum and plasma</td><td colspan="1" rowspan="1">used for the quantitative in vitro diag-nostic determination of sodium (Na*),potassium (K†), and chloride (Cl) indiluted serum, plasma and urine</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">Sodium measurements are used inthe diagnosis and treatment of elec-trolyte and metabolic disorders.Potassium measurements are used tomonitor electrolyte balance in thediagnosis and treatment of diseasesconditions characterized by low orhigh blood potassium levels.Chloride measurements are used inthe diagnosis and treatment of elec-trolyte and metabolic disorders.</td><td colspan="1" rowspan="1">Sodium measurements are used inthe diagnosis and treatment of aldos-teronism (excessive secretion of thehormone aldosterone), diabetes in-sipidus (chronic excretion of largeamounts of dilute urine, accompaniedby extreme thirst), adrenal hyperten-sion, Addison's disease (caused bydestruction of adrenal glands), dehy-dration, inappropriate antidiuretichormone secretion, or other diseasesinvolving electrolyte imbalancePotassium measurements are used tomonitor electrolyte balance in thediagnosis and treatment of diseasesconditions characterized by low orhigh blood potassium levels.Chloride measurements are used inthe diagnosis and treatment of elec-trolyte and metabolic disorders suchas cystic fibrosis and diabetic acido-sis.</td></tr><tr><td colspan="1" rowspan="1">Test principle</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">• "</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Indirect potentiometry measurementwith lon-Selective Electrode</td><td colspan="1" rowspan="1">Indirect potentiometry measurementwith lon Selective Electrode</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">Serum and hemolysis-free plasma</td><td colspan="1" rowspan="1">Serum, plasma</td></tr><tr><td colspan="1" rowspan="1">General information</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Sodium:Serum/plasma : 136-145 mmol/LPotassium:Serum: 3.5 -5.1 mmol/LPlasma: 3.4 - 4.5 mmol/LChloride:Serum/Plasma: 98 - 107 mmol/L</td><td colspan="1" rowspan="1">Sodium (adults):Serum/plasma: 136-145 mmol/LPotassium (adults):Serum: 3.5 -5.1 mmol/LPlasma: 3.4 - 4.5 mmol/L"-;Chloride (adults):::Serum/plasma: 98 - 107 mmol/L</td></tr></table>

<table><tr><td>Performance characteristics Method comparison</td><td colspan="4"></td></tr><tr><td></td><td rowspan="13"></td><td colspan="2">Sodium on serum y=1.042 x -6.9 mEq/L</td><td>Sodium on serum y=0.986 x - 0.364 mmol/L r= 0.983</td></tr><tr><td>r= 0.996 range: 83 to 196.2 mEq/L</td><td colspan="2"></td><td>range: 130 to 146 mmol/L</td></tr><tr><td colspan="2">Potassium on serum y=1.008 x - 0.08 mEq/L r= 0.997</td><td colspan="2">Potassium on serum</td></tr><tr><td colspan="2">range: 2.06 to 11.75 mEq/L</td><td colspan="2">y=0.984 x - 0.003 mmol/L r= 1.000</td></tr><tr><td colspan="2">Chloride on serum y=0.950 x + 3.5 mEq/L</td><td colspan="2">range: 3.3 to 11.83 mmol/L</td></tr><tr><td colspan="2">r= 0.992 range: 70.2 to 166.8 mEq/L</td><td colspan="2">Chloride on serum y=1.014 x - 3.236 mmol/L</td></tr><tr><td colspan="2">Sodium: Unconjugated bilirubin: No signifi-</td><td colspan="2">r= 0.982 range: 91 to 106 mmol/L</td></tr><tr><td colspan="2">μmol/L). pmol/L).</td><td colspan="2">Sodium : Serum/plasma Hemolysis: Avoid hemolyzed speci- cant interference up to 36 mg/dL (616 mens. No significant interference up Conjugated bilirubin: No significant</td></tr><tr><td colspan="2"></td><td colspan="2">to 1000 mg/dL of hemoglobin Icterus: No significant interference up interference up to 25 mg/dL (427 to 60 mg/dL bilirubin Turbidity: No significant interference</td></tr><tr><td colspan="2">up to 614 mg/dL (7 mmol/L). Acetylsalicylate: No significant inter-</td><td colspan="2">Lipemia: No significant interference up to 2000 mg/dL of triglycerides Dysproteinemia: No significant inter- ference up to 3000 mg/dL</td></tr><tr><td colspan="2">ference up to 50 mg/dL (2.7 mmol/L). Ascorbic acid: No significant inter- ference up to 20 mg/dL (1.1 mmol/L).</td><td colspan="2">Drugs: A panel of drugs was tested and caused no significant interfer-</td></tr><tr><td colspan="2">Hyperlipemia or hyperproteinemia lead to a negative bias in the meas- urement of electrolyte because of</td><td colspan="2">ences when added to aliquots of pooled normal human serum/plasma up to the indicated concentration.</td></tr><tr><td colspan="2">dilution effect. Potassium: Unconjugated bilirubin: No signifi-</td><td colspan="2"></td></tr><tr><td colspan="2">cant interference up to 36 mg/dl (616 μmol/L). Conjugated bilirubin: No significant interference up to 25 mg/dL (427 µmol/L).</td><td colspan="2">Potassium : Serum/plasma Hemolysis: Avoid hemolyzed speci- mens. No significant interference up to 100 mg/dL of hemoglobin. Potas-</td></tr></table>

<table><tr><td colspan="3">because of high potassium concentra- Drugs: A panel of drugs was tested</td></tr><tr><td rowspan="5">Traceability</td><td>tion in erythrocytes. Hyperlipemia or hyperproteinemia lead to a negative bias in the meas- urement of electrolyte because of dilution effect.</td><td>and caused no significant interfer- ences when added to aliquots of pooled normal human serum/plasma up to the indicated concentration.</td></tr><tr><td>Chloride: Unconjugated bilirubin: No signifi- cant interference up to 36 mg/dL (616 μmol/L). Conjugated bilirubin: No significant interference up to 25 mg/dL (427</td><td>Chloride: Serum/plasma Hemolysis: Avoid hemolyzed speci- mens. No significant interference up to 1000 mg/dL of hemoglobin. Icterus: No significant interference up to 60 mg/dL bilirubin. Lipemia: No significant interference</td></tr><tr><td>μmol/L). Turbidity: No significant interference up to 614 mg/dL (7 mmol/L). Acetylsalicylate: No significant inter- ference up to 50 mg/dL (2.7 mmol/L). Ascorbic acid: No significant inter- ference up to 20 mg/dL (1.1 mmol/L).</td><td>up to 2000 mg/dL of triglycerides Dysproteinemia: No significant inter- ference up to 3000 mg/dL. Drugs: A panel of drugs was tested and caused no significant interfer- ences when added to aliquots of pooled normal human serum/plasma</td></tr><tr><td>Hyperlipemia or hyperproteinemia lead to a negative bias in the meas- urement of electrolyte because of dilution effect.</td><td>up to the indicated concentration. In addition to the tested drug panel, sali- cylic acid measured. The highest con- centration (5 mmol/L) causes artifi- cially elevated chloride concentrations</td></tr><tr><td>According the following reference material : Na*:NIST SRM 919b K*NIST SRM 918b Cl NIST SRM 918b/919b</td><td>This method has been standardized against primary calibrators prepared gravimetrically from purified salts.</td></tr><tr><td>Calibration Frequency</td><td>It is recommended to recalibrate after setting-up of a new vial of ISE Refer- ence Solution or of ISE Diluent then every 4 hours when quality control results fall outside the established</td><td>24 hours (main calibration) after ISE cleaning and maintenance, after changing the reagent bottles after replacing electrodes</td></tr><tr><td>ISE CALIBRATOR</td><td>range, after replacing electrode, and after ISE cleaning and maintenance ELITech Clinical Systems Device (ISE Calibrator)</td><td>Predicate device Roche Standards for the Cobas ISE Module K897071</td></tr><tr><td>ISE Calibrators</td><td>Composition: Aqueous solutions containing sodium, potassium and chloride with 2 differ-</td><td>ISE Calibration kit Composition: Aqueous preparations with different</td></tr><tr><td></td><td>ent levels of concentrations. Concentrations are lot-specific. The values are given in the vial labels.</td><td>levels of concentrations level 1 and level 2 "- ISE Solution 1 : Na*: 150 mmol/L K*: 5 mmol/L</td></tr><tr><td></td><td>Storage: Store at 2-30 °C. These calibrators are stable until the expiry date stated on the label.: Do not freeze. Stability: - Calibrators are stable until the expiry date stated on the label. - After opening, calibrators is stable 30 days when stored at 2-30 C Note: Calibrators should be immedi- ately and tightly capped to prevent contamination and evaporation. stable until the expiry date stated on the label.</td><td>Cr: 115 mmol/L ISE Solution 2 : Nat:110 mmol/L K*: 1.8 mmol/L Cr: 72 mmol/L Storage: Store at 2-8 C. These calibrators are stable until the expiry date stated on the label. Stability: - Calibrators are stable until the expiry date stated on the label. - After opening, calibrators is stable 4 weeks when stored at 2-8 C Note: Close opened bottles immedi- ately after use and store at 2-8 C. ISE Calibrator indirect /urine Composition: Sodium (Na) : 25 mmol/L Potassium (K*) : 0.83 mmol/L Chloride (Cl): 19.2 mmol/L Storage: Store at 15-25 C. This solution is</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of this device versus the predicate device is not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate devices in its intended use locations.

ELITech Group Vital Scientific BV c/o Debra Hutson ELITech Group Epoch Biosciences $2 1 7 2 0 2 3 ^ { \mathrm { r d } }$ Dr. SE, Suite 150 Bothell, Washington 98021

Re: k102647 Trade Name: AST/GOT $4 + 1$ SL Regulation Number: 21 CFR $\ S 8 6 2 . 1 1 0 0$ Regulation Name: Aspartate aminotransferase (AST/SGOT) Test System Regulatory Class: Class II Product Codes: CIT, JGS, CEM, CGZ, JIX, JJY and JJE Dated: March 4, 2011 Received: March 7, 2011

Dear Ms. Hutson:

We have reviewed your Section $5 1 0 ( \mathrm { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796- 5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

GC.

Coukthey Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety •   
Center for Devices and Radiological Health

# Indications for Use Form

510() umbe

Device Name:  ELITech Clinical Systems Selectra ProM

Indications for Use:

The ELITech Clinical system Selectra ProM is an automated clinical chemistry system intended for use in clinical laboratories. It is intended to be used for a variety of assay methods that have been appled to spectrophotometric and electrochemical techniques. The system has two core modules: one consisting of a spectrophotometric system for measurement of analytes using spectrophotometric techniques, such as end point, rate and turbidimetric assays. The second module is an electrometer used for measurement of electrolytes.

For in vitro diagnostic use only.

Prescription Use __X (Part 21 CFR 801 Subpart D)

AND/OR

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/b0224ae323ec2764f3533a9240610ead51e227a184549c6f9063fb74134dd431.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

page: 1 of6

# Indications for Use Form

510(k) Number (f know247

Device Name: __ ELITech Clinical Systems AST/GOT 4+1 SL_

Indications for Use:

ELITech Clinical Systems AST/GOT $4 + 1$ SL is a reagent for the quantitative in vitro diagnostic determination of the activity of the enzyme Aspartate Amino Transferase (AST) in human serum and plasma on ELITech Clinical Systems Selectra ProM analyzer. Aspartate Amino Transferase measurements are used in the diagnosis and treatment of certain types of liver and heart disease.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/b233ea552721a330d9c0dc0d77b636db7445e55125b56a8858df5ec966682cbf.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510k) Nume (f known): $h _ { 1 0 2 , \log 7 }$

Device Name: ELITech Clinical Systems ISE Na, K, CI Electrodes

Indications for Use:

# ISE Sodium Electrode

The sodium electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of sodium in serum and plasma. Sodium measurements are used in the diagnosis and treatmentf aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction  the adrenal glands), dehydration,inappropriate antidiuretic hormone secretion or other diseases involving electrolyte imbalance.

# ISE Potassium Electrode

The potassium electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of potassium in serum and plasma. Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

# ISE Chloride Electrode

The Chloride electrode for the ELITech Clinical Systems Selectra ProM is intended for the quantitative determination of chloride in serum and plasma.Chloride measurements are used in the diagnosis an treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/221ab4e6676859fc801ccb9a962afc402a40770eec4a223f2237a8269f9d11c6.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (f known1 Device Name: ELITech Clinical Systems ELITROL I & ELITROLII

Indications for Use:

AND/OR

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/39012b36b1030a09e4d5374901e8c90e2954ccea183f415e8cd943ba7c0536a1.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k Numberkow

Device Name: _ELITech Clinical Systems ISE Calibrators_ Indications for Use:

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/ef93d7d6a433f285b461bdd894c3a0898f33b20700659a2af27f3586ab64c745.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number(i know

Device Name: __ELITech Clinical Systems ELICAL2_

Indications for Use:

Prescription Use __X (Part 21 CFR 801 Subpart D)

AND/OR

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/65ea1f947ffeaf737f5a6e91c2de69f25cf6b6b5107249c77b9644ef2fcc6181.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety